FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was organized by [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise awareness that [...]
CVBF’s Scientific Director to Speak at Rare Disease & Orphan Drugs Congress
Giovanni Migliaccio, Scientific Director of CVBF and member of the Board of Directors of the European Paediatric Translational Research Infrastructure (EPTRI), will [...]
New Clinical Trial Seeks to Slow Progression of Nearsightedness in Children
A new international clinical trial is underway across Europe to test whether low-dose atropine eye drops can effectively slow the [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as [...]
New Article on Gabapentin and Tramadol in Paediatric Patients with Chronic Pain
A new article published on 6 October 2023 in the Journal of the British Pharmacological Society titled"Dose rationale for gabapentin [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working [...]
CVBF spotlight on scientific literature: “Why children have to wait years for new drugs”
This recent article is part of Nature Outlook: Children‘s health and focuses on the lack of medicines approved for paediatric use. According to the article, [...]
First gene therapy to treat haemophilia B
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Hemgenix (etranacogene dezaparvovec), the the first gene therapy for the treatment [...]
Event: The next steps for a real European Health Union – Delivering patient care through digital solutions
This in-person event, organized by the European Association of E-Pharmacies (EAEP) will be held on Thursday, 27 October at TownHall Europe (Square de Meeûs 5, [...]
CVBF participates in the Smarter Programme For Technological Innovation
Thanks to the close collaboration with Aldo Moro University of Bari, Exprivia spa and Hero srl, and following the agreement signed with the Ministry of University [...]
CVBF September Special Issue
This new Special Issue is dedicated to the active involvement of CVBF in the European Joint Programme for Rare Diseases (EJP RD), a consortium that [...]
Scientific publication: Patient-Reported Outcome Measures in Clinical Research
The “Patient-Reported Outcome Measures in Clinical Research” research paper describes the importance and also some limitations of the use of patient-reported outcome measures (PROMs) in [...]